Newsroom
Sorted by: Latest
-
Point2、アーム、LBインベストメント、マーベリック・シリコンから1億3600万ドルのシリーズB資金調達を完了
米カリフォルニア州サンノゼ--(BUSINESS WIRE)--(ビジネスワイヤ) -- AIデータセンターインフラ向けのRFベースの相互接続ソリューションを開発するPoint2 Technology(Point2)は、LBインベストメントが主導し、アームが新たに戦略的投資家として参加し、さらにマーベリック・シリコンを含む既存の投資家が継続して支援する形で、シリーズB資金調達をさらに拡大したと発表しました。今回の調達により、シリーズBの調達総額は1億3600万ドルに達しました。 今回の投資により、NVIDIA、アーム、UMCキャピタル、モレックス、ボッシュ・ベンチャーズといった有力企業を含む支援企業の顔ぶれがさらに拡充されました。これは、半導体、アクセラレータ、相互接続エコシステム全体で勢いが増していることを反映しており、次世代AIデータセンター向けの新たなラックスケールの相互接続基盤としてのPoint2のe-Tube™テクノロジープラットフォームの地位をさらに強固なものにします。 Point2は調達した資金を、エンジニアリング、システム、オペレーション、およびビジネス部門の強化に充...
-
Point2完成1.36億美元B輪融資,Arm、LB Investment和Maverick Silicon領投
加州聖荷西--(BUSINESS WIRE)--(美國商業資訊)-- 專注於人工智慧資料中心基礎設施的射頻互連解決方案開發商Point2 Technology今天宣布,其由LB Investment領投的B輪融資獲得追加投資,Arm作為新的策略投資人加入,包括Maverick Silicon在內的現有投資人也持續參與本輪融資。此次追加投資使B輪融資總額達到1.36億美元。 此次投資進一步擴大了Point2的知名投資人陣容,包括NVIDIA、Arm、UMC Capital、Molex、Bosch Ventures以及其他新老投資人,反映出半導體、加速器及互連生態系統正呈現加速發展的態勢,並進一步鞏固了Point2的e‑Tube™技術平台作為次世代人工智慧資料中心全新機架級互連基礎的地位。 Point2將利用這筆資金加強其工程、系統、營運和業務團隊,以加速其主動式射頻纜線(ARC)、近封裝e-Tube(NPE)和共封裝e-Tube(CPE)解決方案的商業化,這些解決方案將應用於未來的機架級運算系統。 「隨著人工智慧系統規模的擴大,以及頻寬需求達到太位元每秒的速度,互連已成為關鍵瓶頸。」Po...
-
Ramos Law Expands Phoenix Team with Addition of Arizona Attorney Dean Fox
PHOENIX--(BUSINESS WIRE)--Phoenix personal injury attorney Dean Fox joins Ramos Law, bringing nearly 20 years of experience handling complex injury and accident claims....
-
Modiv Industrial Stockholders Approve Merger with Global Net Lease
DENVER--(BUSINESS WIRE)--Modiv Industrial, Inc. (“Modiv Industrial,” “Modiv” or the “Company”) (NYSE:MDV) announced today that Modiv's common stockholders have approved the previously announced acquisition of Modiv Industrial by Global Net Lease, Inc. (NYSE:GNL) (the "Transaction") at the special meeting of Modiv’s common stockholders held earlier today (the “Special Meeting"). At the Special Meeting, approximately 94% of the votes cast were voted in favor of the Transaction, which represented...
-
KBRA Assigns Preliminary Ratings to FCR 2026-FL1
NEW YORK--(BUSINESS WIRE)--KBRA is pleased to announce the assignment of preliminary ratings to eight classes of FCR 2026-FL1, a managed CRE CLO securitization with the ability to reinvest principal proceeds for 24 months. The transaction will initially be collateralized by 29 mortgage loans with an aggregate cutoff date in-trust balance of $900.0 million. Additionally, the transaction provides the sponsor with the ability to effectuate modifications to performing loans, as well as buy out defa...
-
Griffon Corporation Announces Pricing of $800 Million Senior Notes Offering
NEW YORK--(BUSINESS WIRE)--Griffon Corporation (NYSE: GFF) (“Griffon”) today announced the pricing of $800 million aggregate principal amount of its senior notes due 2034 (the “Notes”) in an unregistered offering through a private placement. The Notes will pay interest semi-annually at a rate of 6.25% per annum. The Notes will be senior unsecured obligations of Griffon and will be guaranteed by certain of its domestic subsidiaries. The sale of the Notes is expected to close on August 18, 2026,...
-
Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to contain glass particles. Risk Statement: The administration of an injectable product containing glass particulates may cause local irritation, pain, or swelling at the infusion site, as well as inflammation of the veins. More se...
-
Walker & Dunlop Investment Partners Delivers $242 Million in Multifamily Bridge Lending as Private Credit Opportunity Grows
BETHESDA, Md,--(BUSINESS WIRE)--Walker & Dunlop Investment Partners (WDIP) closed nearly $242 million of multifamily bridge loans in the second quarter of 2026....
-
Silvec Announces EPA Registration for its Novel Therapy Delivery Technology
GAITHERSBURG, Md.--(BUSINESS WIRE)--Silvec Biologics Inc., a Maryland-based agricultural biotechnology company, is pleased to announce that its novel RNA-based therapy delivery product is now registered for unconditional commercial use under the U.S. Environmental Protection Agency’s (EPA) Federal Insecticide, Fungicide and Rodenticide Act. The product is based on a naturally non-transmitted version of the citrus tristeza virus that is already found in most Florida citrus trees that has been re...
-
Sherritt Comments on Press Release Regarding Recapitalization Proposal
TORONTO--(BUSINESS WIRE)--Sherritt International Corporation (“Sherritt” or the “Corporation”) (TSX:S) today confirms receipt of an unsolicited, non-binding proposal from a consortium comprised of Kyma Capital, Glencore Ltd. and a United States anchor investor (collectively, the “Consortium”). The Corporation cautions stakeholders that the Consortium’s proposal is non-binding, conditional and is not currently executable. Sherritt will address all proposals from current or potential stakeholders...